IMBRIANO, Carol
 Distribuzione geografica
Continente #
NA - Nord America 8.092
EU - Europa 3.980
AS - Asia 1.739
SA - Sud America 69
OC - Oceania 22
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.920
Nazione #
US - Stati Uniti d'America 8.068
IT - Italia 1.373
GB - Regno Unito 970
SG - Singapore 696
SE - Svezia 539
CN - Cina 444
HK - Hong Kong 239
DE - Germania 231
FR - Francia 158
UA - Ucraina 151
FI - Finlandia 125
RU - Federazione Russa 93
ID - Indonesia 89
TR - Turchia 81
BG - Bulgaria 66
CZ - Repubblica Ceca 60
BR - Brasile 55
BE - Belgio 46
JP - Giappone 45
VN - Vietnam 45
IN - India 44
ES - Italia 37
IE - Irlanda 37
LT - Lituania 26
AU - Australia 22
CA - Canada 22
NL - Olanda 21
MY - Malesia 12
EG - Egitto 11
CH - Svizzera 9
KR - Corea 9
IR - Iran 8
PL - Polonia 6
AR - Argentina 5
BD - Bangladesh 5
IL - Israele 5
CL - Cile 4
PT - Portogallo 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
DK - Danimarca 3
EC - Ecuador 3
EE - Estonia 3
EU - Europa 3
RO - Romania 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
GR - Grecia 2
IQ - Iraq 2
LU - Lussemburgo 2
NO - Norvegia 2
PH - Filippine 2
SI - Slovenia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CO - Colombia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
PA - Panama 1
PK - Pakistan 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 13.920
Città #
Fairfield 1.058
Santa Clara 1.022
Southend 758
Woodbridge 658
Ashburn 630
Chandler 594
Singapore 501
Houston 427
Seattle 386
Ann Arbor 382
Cambridge 355
Wilmington 338
Modena 306
Nyköping 303
Jacksonville 294
Dearborn 256
Hong Kong 226
Bologna 130
Milan 103
San Diego 94
Beijing 93
Jakarta 89
New York 87
Helsinki 69
Princeton 69
Sofia 66
Reggio Emilia 60
Eugene 59
Parma 54
Bremen 51
Izmir 51
Shanghai 49
Brno 45
Dong Ket 45
Fremont 43
Brussels 40
Moscow 36
London 31
Dublin 29
Durham 29
Redwood City 29
Boardman 27
Tokyo 27
Falls Church 24
Des Moines 23
Rome 22
Norwalk 21
Phoenix 21
Medesano 20
Munich 18
Turin 17
Chicago 15
Hefei 15
San Mateo 15
Los Angeles 14
Perugia 14
Campagna Lupia 13
Paris 13
Valencia 13
Florence 12
Olomouc 12
San Jose 12
Central 11
Dallas 11
Leawood 11
Frankfurt am Main 10
Genoa 10
Lappeenranta 10
São Paulo 10
Trento 10
Augusta 9
Barcelona 9
Collecchio 9
Guangzhou 9
Kunming 9
Sassuolo 9
Asyut 8
Cadelbosco di Sopra 8
Chengdu 8
Jinan 8
Naples 8
Romainville 8
Strasbourg 8
Toronto 8
Verona 8
Nanjing 7
Palermo 7
Piacenza 7
Saint Petersburg 7
Washington 7
Andover 6
Edinburgh 6
Imola 6
Monmouth Junction 6
Morgantown 6
Ottawa 6
Serramazzoni 6
Acton 5
Buffalo 5
Carpi 5
Totale 10.614
Nome #
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 310
Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells 291
An autoregulatory loop controls the expression of the transcription factor NF-Y 279
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 275
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 268
NF-Y activates genes of metabolic pathways altered in cancer cells 265
NF-YA splice variants have different roles on muscle differentiation 258
Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters 257
Curcumin derivatives and Aβ-fibrillar aggregates: An interactions’ study for diagnostic/therapeutic purposes in neurodegenerative diseases 246
Direct non transcriptional role of NF-Y in DNA replication 241
Dissection of the NF-Y transcriptional activation potential 240
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 237
NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s 233
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 231
Alternative splicing of transcription factors genes in muscle physiology and pathology 231
Curcumin derivatives: molecular basis of their anti-cancer activity. 230
bis-Dehydroxy-Curcumin Triggers Mitochondrial-Associated Cell Death in Human Colon Cancer Cells through ER-Stress Induced Autophagy. 229
Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking 226
NF-Y co-associates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. 224
NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription 222
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 221
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 221
Ternary complex formation between MADS-box transcription factors and the histone fold protein NF-YB 220
Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63 219
An acetylation-mono-ubiquitination switch on lysine 120 of H2B. 214
Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2 213
Probing solute–solvent hydrogen bonding with fluorescent water-soluble curcuminoids 208
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates 207
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 204
NF-Y splice variants differentially affect skeletal myogenesis 204
Specific inhibition of NF-Y subunits triggers different cell proliferation defects. 203
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 200
The NF-Y/p53 liaison: Well beyond repression. 193
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 192
Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters 191
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 190
Switch of NF-YA splice variants in prostate cancer development and progression 190
HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes 189
DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters via p53 C-terminal lysines 187
New curcumin-derived ligands and their affinity towards Ga3+, Fe3+and Cu2+: Spectroscopic studies on complex formation and stability in solution 186
Development of new metal-chelating multi target drus derived from Curcumin 184
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads 183
Cloning and characterization of the histone-fold proteins YBL1 and YCL1 177
NF-YC complexity is generated by dual promoters and alternative splicing 176
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 168
A non transcriptional role for NF-Y in DNA replication 156
The transcription factor NF-Y is required for satellite stem cell proliferation and skeletal muscle tissue repair 152
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 151
Role of the transcriprion factor NF-Y in cell cycle regulation 149
Direct non transcriptional role of the CCAAT-factor NF-Y in DNA replication 146
Expression of the CCAAT-binding factor NF-Y in Caenorhabditis elegans 145
The interplay between NF-Y, AR and lipid metabolism regulates tumor aggressiveness in prostate cancer. 143
Dysregulation of NF–Y splicing drives metabolic rewiring and aggressiveness in colon cancer 141
Development of new therapeutic Metal(III)-chelating agents derived from Curcumin 141
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 141
Development of new metal-based phyto-radiopharmaceuticals: diagnostic agents derived from Cur(e)cumin 141
In situ immunofluorescent staining of autophagy in muscle stem cells 138
Alternative splicing of the transcription factor NF-Y promotes cell migration and invasion in colon cancer 133
Understanding the molecular mechanisms of Curcumin derivatives chemotherapic activity 133
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 129
Monitoring DNA Hybridization with Organic Electrochemical Transistors Functionalized with Polydopamine 127
DNA damage promotes HDAC4 nuclear localization and G2/M promoters repression via p53 C-terminal lysisnes 122
NF-Y LOSS REACTIVATES p53 AND TRIGGERS p53-DEPENDENT APOPTOSIS IN HPV-POSITIVE HUMAN CERVICAL CARCINOMA CELLS 120
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 119
The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 112
The NF-YA splicing signature controls aggressiveness of colon cancer by regulating different modes of cell migration and cell metabolism. 105
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 100
The transcription factor NF-Y is required for satellite stem cell myogenic progression and skeletal muscle tissue repair 98
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 97
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 91
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 88
The NF-YA Splicing Signature Controls Aggressiveness of Colon Cancer by Regulating Cell Metabolism and Different Types of Cell Migration 85
Development of Stable Amino-Pyrimidine–Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity 76
Deciphering the transcriptional network of NF-Y in prostate cancer development and progression 72
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 71
Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer? 69
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 63
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 59
Alterations in NF-Y splicing enable the metabolic plasticity of colon cancer cells and foster dynamic interactions within the tumor niche 54
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 53
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 41
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function 40
Investigation of transcription factor–DNA binding with electrolyte-gated organic transistors 36
Cell cycle regulation of NF-YC nuclear localization 35
Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex 35
The role(s) of NF-Y in development and differentiation 26
Cross-talk between NF-Y transcription factor and m6A epitanscriptomic regulators in colon cancer: molecular characterization and clinical relevance. 18
The transcription factor NF-Y participates in prostate cancer progression and response to androgen-deprivation therapy 14
Totale 14.098
Categoria #
all - tutte 53.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.574 0 0 0 0 0 342 383 238 254 104 133 120
2020/20212.197 217 117 153 148 229 168 170 205 105 318 206 161
2021/20221.672 78 147 175 113 75 111 101 72 202 135 297 166
2022/20231.966 199 260 125 173 202 246 56 182 204 52 153 114
2023/20241.707 63 80 107 155 300 135 249 144 32 68 142 232
2024/20252.391 146 56 214 336 889 750 0 0 0 0 0 0
Totale 14.098